| William Clifford Taylor, MD | |
|
106 Milford St. Ste 201, Salisbury, MD 21804 | |
| (410) 543-1952 | |
| (410) 543-8497 |
| Full Name | William Clifford Taylor |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 106 Milford St. Ste 201, Salisbury, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063508539 | NPI | - | NPPES |
| 114518 | Other | MD | COVENTRY |
| 52412402 | Other | MD | BLUE CROSS BLUE SHIELD |
| 072831400 | Medicaid | MD | |
| G1130001 | Other | MD | BLUE CHOICE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | D0038162 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Clifford Taylor, MD 106 Milford St Ste 201, Salisbury, MD 21804-6959 Ph: (410) 543-1616 | William Clifford Taylor, MD 106 Milford St. Ste 201, Salisbury, MD 21804 Ph: (410) 543-1952 |
News Archive
SGLT-2 inhibitors are a relatively new class of diabetes drugs that have shown many benefits for people with type 2 diabetes who have not responded well to previous interventions, including diet changes and metformin.
Boston Scientific Corporation today announced it has received CE Mark approval for its TAXUS Element Paclitaxel-Eluting Coronary Stent System, the Company's third-generation drug-eluting stent technology. This approval includes a specific indication for the treatment of diabetic patients.
The use of electronic discharge orders aimed at providing evidence-based decision support and clear instructions to heart failure patients helped increase compliance with quality care measures and lowered hospital readmission rates, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session.
Merz Pharma Group announced today that the subsequent offering period of the tender offer by Merz GmbH & Co. KGaA ("Merz") and its acquisition subsidiary to purchase all of the outstanding shares of common stock of BioForm Medical, Inc. at a price of $5.45 per share, net to the seller in cash (without interest thereon and less any required withholding tax) expired as scheduled at 12:00 midnight, Eastern Standard Time, on February 18, 2010.
In a large five nation study from Europe it was seen that the use of adjuvanted vaccines against the pandemic H1N1 influenza virus probably did not increase the risk of Guillain-Barré Syndrome (GBS), but the investigators could not firmly rule out a slightly greater chance of suffering the paralytic condition.
› Verified 2 days ago
Kimberly Cuomo, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 100 E Carroll Street, Salisbury, MD 21801 Phone: 410-543-7536 Fax: 410-543-7272 | |
Gul Ghutai Manalai, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 106 Pine Bluff Rd, #11, Salisbury, MD 21801 Phone: 410-742-2255 Fax: 470-742-2589 | |
Andras Kovacs, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 106 Milford St. Ste 201, Salisbury, MD 21804 Phone: 410-543-1616 Fax: 410-543-8497 | |
Jennifer Lynn Wehberg, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1415 Wesley Dr, Salisbury, MD 21801 Phone: 410-912-7000 Fax: 410-912-4202 | |
Dr. Stephen Michael Cooper, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 223 Phillip Morris Dr, Salisbury, MD 21804 Phone: 410-548-1747 Fax: 410-548-3783 | |
Mohan Kumar Thummalapalli, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 106 Milford St Ste 201, Salisbury, MD 21804 Phone: 410-543-1616 Fax: 410-543-8497 |